Commentary to Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update
High Blood Press Cardiovasc Prev
.
2021 May;28(3):251-252.
doi: 10.1007/s40292-021-00446-w.
Epub 2021 Apr 1.
Authors
Claudio Ferri
1
,
Giovambattista Desideri
2
,
Rita Del Pinto
2
Affiliations
1
Department MeSVA, University of L'Aquila, L'Aquila, Italy. claudio.ferri@univaq.it.
2
Department MeSVA, University of L'Aquila, L'Aquila, Italy.
PMID:
33792849
PMCID:
PMC8014900
DOI:
10.1007/s40292-021-00446-w
No abstract available
Publication types
Letter
Comment
MeSH terms
Angiotensin-Converting Enzyme 2
Angiotensins
COVID-19*
Humans
Renin-Angiotensin System*
SARS-CoV-2
Substances
Angiotensins
Angiotensin-Converting Enzyme 2